Hoth Therapeutics Expands Intellectual Property Portfolio with Acquisition of New Patent Applications
Hoth Therapeutics(HOTH) Prnewswire·2025-01-21 13:29IP will be used to pursue further indications for HT-001 Cancer TherapeuticNEW YORK, Jan. 21, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, proudly announces advancements in its intellectual property portfolio through the acquisition and expansion of patent applications to its innovative therapeutic pipeline.These newly secured patents reflect Hoth's commitment to pioneering cutting-edge treatments that address unmet medical needs, with a focus on ...